STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDWK
  4. [Form 4] MDWerks, Inc. Insider Trading Activity

MDWerks (NASDAQ: MDWK) director reports 146,546-share equity awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Milner Roy Monroe reported acquisition or exercise transactions in this Form 4 filing.

MDWerks, Inc. director Milner Roy Monroe reported two stock awards of common shares received as compensation under his employment agreement and the MDWerks, Inc. 2025 Equity Incentive Plan. He was granted 100,000 shares on February 11, 2026 at $0.15 per share and 46,546 shares on May 15, 2026 at $0.13 per share, both approved by the board and issued in accordance with Rule 16b-3. After these awards, he holds 146,546 common shares directly. The company notes that the Form 4 for the February 11, 2026 grant was inadvertently not filed at the time of that earlier issuance.

Positive

  • None.

Negative

  • None.
Insider Milner Roy Monroe
Role null
Type Security Shares Price Value
Grant/Award Common Stock 46,546 $0.13 $6K
Grant/Award Common Stock 100,000 $0.15 $15K
Holdings After Transaction: Common Stock — 146,546 shares (Direct, null)
Footnotes (1)
  1. Represents the grant of shares of common stock issued pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on February 11, 2026 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended. The Form 4 for this issuance was inadvertently not reported at the time of issuance. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on February 11, 2026 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.
February 11, 2026 grant 100,000 shares at $0.15/share Common Stock award under employment agreement
May 15, 2026 grant 46,546 shares at $0.13/share Quarterly Common Stock award under employment agreement
Total direct holdings 146,546 shares Common Stock held after May 15, 2026 grant
Number of awards 2 grants Compensation-related stock awards reported in this Form 4
MDWerks, Inc. 2025 Equity Incentive Plan financial
"issued under the MDWerks, Inc. 2025 Equity Incentive Plan."
Rule 16b-3 regulatory
"issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Employment Agreement financial
"pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on February 11, 2026"
grant of shares of common stock financial
"Represents the grant of shares of common stock issued pursuant to the Employment Agreement"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Milner Roy Monroe
(Last)(First)(Middle)
411 WALNUT STREET, SUITE 20125
(Street)
GREEN COVE SPRINGS, FLORIDA 32043
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
MDWerks, Inc. [ MDWK ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock02/11/2026A100,000(1)A$0.15100,000D
Common Stock05/15/2026A46,546(2)A$0.13146,546D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the grant of shares of common stock issued pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on February 11, 2026 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended. The Form 4 for this issuance was inadvertently not reported at the time of issuance.
2. Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on February 11, 2026 and issued under the MDWerks, Inc. 2025 Equity Incentive Plan. The grant of shares was approved by the Issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended.
/s/ Roy Monroe Milner05/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MDWerks (MDWK) director Milner Roy Monroe report?

Director Milner Roy Monroe reported receiving common stock awards as compensation. He was granted 100,000 shares on February 11, 2026 and 46,546 shares on May 15, 2026, all under his employment agreement and the MDWerks, Inc. 2025 Equity Incentive Plan.

How many MDWerks (MDWK) shares does Milner Roy Monroe hold after these grants?

After the reported grants, Milner Roy Monroe holds 146,546 MDWerks common shares directly. This total reflects both the 100,000-share award on February 11, 2026 and the 46,546-share award on May 15, 2026, as disclosed in the Form 4 filing.

Were Milner Roy Monroe’s MDWerks (MDWK) share awards open-market purchases?

No, the transactions are stock awards, not open-market purchases. Both grants were issued as compensation under his employment agreement and the MDWerks, Inc. 2025 Equity Incentive Plan, approved by the board and made in accordance with Rule 16b-3.

What are the grant prices for Milner Roy Monroe’s MDWerks (MDWK) stock awards?

The February 11, 2026 award was priced at $0.15 per share for 100,000 shares. The May 15, 2026 quarterly award was priced at $0.13 per share for 46,546 shares, according to the reported Form 4 compensation grants.

Why does the MDWerks (MDWK) Form 4 mention an earlier February 11, 2026 grant?

The filing explains that the Form 4 for the February 11, 2026 stock grant was inadvertently not reported when originally issued. The current Form 4 therefore includes that 100,000-share award alongside the newer May 15, 2026 quarterly grant.